Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination: a Single Center, Open Cohort Study.

NCT03842631 is registered in ClinicalTrials.gov with XiaoXi Lin as lead sponsor.

NCT NCT03842631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03842631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination: a Single Center, Open Cohort Study.
Lead sponsor
XiaoXi Lin
Phase
Observational
Overall status
Unknown status
Start date
February 16, 2019
Completion date
December 1, 2020
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma